10x Genomics (TXG) Cash from Operations Growth (3y) (2021 - 2026)

10x Genomics (TXG) Cash from Operations Growth (3y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (3y) (Qtr)
1 Veeva Systems 26.11 Bn 18.79 Bn 662.02 Mn 30.60%
2 BrightSpring Health Services 12.95 Bn 12.07 Bn 482.22 Mn 45.52%
3 Healthequity 7.46 Bn 7.19 Bn 256.31 Mn 45.69%
4 Hinge Health 5.15 Bn 4.83 Bn 154.23 Mn -
5 Doximity 3.75 Bn 3.00 Bn 125.97 Mn 32.92%
6 10x Genomics 3.69 Bn 3.15 Bn 106.18 Mn 102.73%
7 Waystar Holding 3.61 Bn 3.45 Bn 268.04 Mn -
8 Privia Health 2.90 Bn 2.54 Bn 595.71 Mn -54.61%
9 Omnicell 1.72 Bn 1.54 Bn 140.36 Mn 62.21%
10 Teladoc Health 1.31 Bn 562.23 Mn 562.57 Mn -10.23%

Historic Data

Download Data
DateValue
Mar 31, 2026 102.73%
Dec 31, 2025 43.77%
Sep 30, 2025 86.80%
Jun 30, 2025 44.93%
Mar 31, 2025 53.99%
Dec 31, 2024 -46.78%
Sep 30, 2024 41.37%
Jun 30, 2024 33.93%
Mar 31, 2024 -56.76%
Dec 31, 2023 30.02%
Sep 30, 2023 23.09%
Jun 30, 2023 26.91%
Mar 31, 2023 -16.99%
Dec 31, 2022 27.00%
Sep 30, 2022 -38.53%
Jun 30, 2022 -83.26%
Mar 31, 2022 -61.76%
Dec 31, 2021 28.34%